Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia - Poland
doi 10.5114/wo.2010.14434
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution Experience

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

A Retrospective Study Evaluating Effectiveness of Concurrent and Adjuvant Temozolamide in Newly Diagnosed Glioblastoma Multiforme in Indian Population.

IOSR Journal of Dental and Medical Sciences
2017English

Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models

Oncotarget
Oncology
2017English

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi
Oncology
2019English

A Phase 1/2 Trial of 5 Fraction Stereotactic Radiosurgery With 5 Mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme: Pattern of Recurrence Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy